Delivery Order SPE2DB22D3011-SPE2DB25FP8UG

Award Date 1/21/25
Potential Completion Date 2/11/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,507.00, is a Firm Fixed Price Delivery Order for COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, with a performance period through December 18, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed-price delivery order contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes with a 0.3ML volume. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,467.00 Firm Fixed Price delivery order contract is for the supply of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a pharmaceutical product, with an ultimate completion date of November 12, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $5,922.24 and an Ultimate Completion Date of February 25, 2025. The contract is for the provision of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, which are likely COVID-19 vaccines. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,002.50 delivery order contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 mL, with a completion date of November 15, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $7,335.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML). The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,322.97, is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 13, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed-price contract is for the delivery of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,146.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a delivery order for COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a vaccine product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML. The contract has a firm fixed price of $7,335 and an ultimate completion date of September 27, 2024. It is a delivery order contract type, and there was no set-aside designation used. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8UG
    Delivery Order

This contract award, valued at $2,961.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3011|SPE2DB25FP8UG) for COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, with an ultimate completion date of February 11, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/22/25, 11:15 AM